Key facts
- Notable investors include Pacific Lake, M2O.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Wu Consulting
- ·The full record, as it builds
Funding rounds
No funding rounds for Wu Consulting are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wu Consulting
Provider of clinical and outcomes research services offering statistical programming, data management, and regulatory support intended to assist life sciences companies through clinical development. The company specializes in SDTM, ADaM, and TFLs in clinical and outcome research, outsourced biostatistics services and analysis for clinical trials, thus helping pharmaceutical companies to win FDA approvals cost-effectively.
- Sector
- Business Products and Services (B2B)
- HQ
- Radnor, PA, United States
- Founded
- 1993
- Employees
- 40
- Website
- wuconsulting.com/
- Ownership
- Privately Held (backing)
Wu Consulting doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wu Consulting shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wu Consulting in its N-PORT filings yet. We sweep new filings monthly.